FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W21624070> ?p ?o ?g. }

• W21624070 endingPage "6" @default.
• W21624070 startingPage "191" @default.
• W21624070 abstract "The principle of our treatment choices for either PTCA or CABG is as follows; 1) 1VD is mainly indicated for PTCA or medical treatment except for very proximal or complicated LAD lesion, 2) 3VD is absolutely indicated for CABG, 3) 2VD involving LAD is positively indicated for CABG, 4) Special indications were set aside for critical lesion(s) in limited groups of patients such as those with prior CABG, and those with other serious or fatal disease, and also senile but active patients (male > 80 years old, female > 75 years old). Proper medial treatment was always conducted in all cases. During the period of 11 years between 1984 and 1994, 1050 PTCA procedures (760 individual patients) and 1484 CABG's were done at our university hospital. The annual ratio between CABG and PTCA (CABG/PTCA) was higher than 2.0 in the first 4 years but it has settled on a level of 1.0 +/- 0.2 in the last 5 years even with a significant increase in the number of PTCA patients. As to the characteristics of our PTCA group, patients with single vessel lesion comprised 57%, only single target PTCA did 78% and only LAD did 47%. Patients with prior CABG and multi lesion PTCA comprised 10% and 22%, respectively. The lesion success rare was 89%. As the major complications in 1050 PTCA's, one death (0.1%), seven (0.7%) emergency CABG's and eleven (1.0%) Q wave MI patients were recognized. The overall angiographical lesion restenosis rate was 44% of 657 lesions in 550 patients who underwent CAG within 6 months after PTCA. In 1484 CABG's, hospital mortality was 1.5% and non fatal major complications 6%. The survival rates (free of cardiac death) for PTCA patient appeared equivalent between single and multi vessel groups. However, their event free survival rates even for 1VD significantly dropped, from 99% to 68% in one year and below 60% at 5 years. For 3VD it became as low as 26% at 10 years. On the contrary, the even free survival rates for CABG patients with 3VD keep as high as 93% at 5 years and 75% at 10 years, respectively. As a conclusion, the timely use of PTCA considering an indication of CABG may be a wise and practical treatment choice for CAD, but the reasonable ratio of PTCA vs CABG seems to be about fifty-fifty as indicated in our study results. Our treatment decisions of either PTCA or CABG as mentioned above yielded acceptable outcomes in the prognosis of patients with CAD." @default.
• W21624070 created "2016-06-24" @default.
• W21624070 creator A5074744079 @default.
• W21624070 creator A5077385516 @default.
• W21624070 creator A5086939418 @default.
• W21624070 date "1996-03-01" @default.
• W21624070 modified "2023-09-27" @default.
• W21624070 title "[Reasonable indication for PTCA or CABG in Japanese patients with coronary artery disease--on the basis of 11 years follow-up]." @default.
• W21624070 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8649328" @default.
• W21624070 hasPublicationYear "1996" @default.
• W21624070 type Work @default.
• W21624070 sameAs 21624070 @default.
• W21624070 citedByCount "2" @default.
• W21624070 crossrefType "journal-article" @default.
• W21624070 hasAuthorship W21624070A5074744079 @default.
• W21624070 hasAuthorship W21624070A5077385516 @default.
• W21624070 hasAuthorship W21624070A5086939418 @default.
• W21624070 hasConcept C126322002 @default.
• W21624070 hasConcept C141071460 @default.
• W21624070 hasConcept C164705383 @default.
• W21624070 hasConcept C2776820930 @default.
• W21624070 hasConcept C2778213512 @default.
• W21624070 hasConcept C2778283817 @default.
• W21624070 hasConcept C2778583881 @default.
• W21624070 hasConcept C2781156865 @default.
• W21624070 hasConcept C71924100 @default.
• W21624070 hasConceptScore W21624070C126322002 @default.
• W21624070 hasConceptScore W21624070C141071460 @default.
• W21624070 hasConceptScore W21624070C164705383 @default.
• W21624070 hasConceptScore W21624070C2776820930 @default.
• W21624070 hasConceptScore W21624070C2778213512 @default.
• W21624070 hasConceptScore W21624070C2778283817 @default.
• W21624070 hasConceptScore W21624070C2778583881 @default.
• W21624070 hasConceptScore W21624070C2781156865 @default.
• W21624070 hasConceptScore W21624070C71924100 @default.
• W21624070 hasIssue "3" @default.
• W21624070 hasLocation W216240701 @default.
• W21624070 hasOpenAccess W21624070 @default.
• W21624070 hasPrimaryLocation W216240701 @default.
• W21624070 hasRelatedWork W1965466849 @default.
• W21624070 hasRelatedWork W1968763737 @default.
• W21624070 hasRelatedWork W2090518947 @default.
• W21624070 hasRelatedWork W2362808561 @default.
• W21624070 hasRelatedWork W2368903981 @default.
• W21624070 hasRelatedWork W2390596188 @default.
• W21624070 hasRelatedWork W2900106712 @default.
• W21624070 hasRelatedWork W2944702342 @default.
• W21624070 hasRelatedWork W3030912428 @default.
• W21624070 hasRelatedWork W3141700921 @default.
• W21624070 hasVolume "97" @default.
• W21624070 isParatext "false" @default.
• W21624070 isRetracted "false" @default.
• W21624070 magId "21624070" @default.
• W21624070 workType "article" @default.